, 79 inflatable penile implant insertions have been performed at our institution by a single surgeon. The objective of this analysis was to compare our in-patient and out-patient experience with penile prosthesis insertion with respect to ease of performance and complication profiles. Data was collected in a prospective manner for both groups (in-patient, n ¼ 33 and out-patient, n ¼ 46). The two groups were compared with respect to intra-operative blood loss, operative time, time lost from work, narcotic use and complication rates. Both groups of patients experienced similar operative blood loss, essentially identical operative times, time lost from work and narcotic use. Most importantly, overall complication rates were 6% for the in-patient group and 4% for the out-patient group. Inflatable penile implant surgery is feasible in an ambulatory surgical setting. There is no difference in complication rates, loss of time from work, or intra-operative and post-operative course. Furthermore, there is a significant saving at our institution by performing the procedure in an out-patient fashion. Inpatient prosthetic surgery is reserved for secondary procedures following a prior implant infection or primary implants in men with significant co-morbidities that require in-patient postoperative monitoring.
Introduction
When the first inflatable penile prosthesis was described by Scott and Timm in 1973, mechanical complications were not uncommon. 1 With significant feedback from urologists, however, several modifications have resulted in prosthetic devices with greater reliability and patient satisfaction. 2 Improvements have included a shift towards inflatable devices, improved biomaterials, and kink-resistant tubing. 3 -5 Recent studies quote mechanical failure rates of 19, 19 and 3.6%, respectively and infection rates between 2.8 and 8.9%. 6, 7 It is estimated that with the increasing age of our population, the number of penile prostheses implanted may also increase significantly. Currently, inflatable devices represent the prosthesis of choice for most patients and clinicians. The two or threepiece models contain two inflatable cylinders coupled with a pump alone or combined with a reservoir. 8 These multi-component models offer patients the greatest simulation of normal flaccidity and normal erection. 9 Historically, penile implant patients were required to remain in the hospital following the operation for observation, antibiotic and analgesia administration. 9, 10 Cost containment and the restructuring of insurance plans, however, has resulted in the increased use of ambulatory surgery settings for many surgical procedures. The resultant effort to move many surgical procedures to an ambulatory setting has impacted upon the field of urology. Recently, workers have demonstrated the feasibility of performing penile prosthesis insertion in an ambulatory setting. 9 -11 This investigation was undertaken to directly compare the ease of performance as well as the complication profiles of penile implant surgery performed in an in-patient and an out-patient setting at a single center by a single surgeon.
Patients and methods
Prior to December 1997, all penile implant surgery was performed in an in-patient setting. Following this date, all primary implants and secondary implant surgery for malfunctioning devices were performed in an ambulatory surgery setting. All patients who underwent implant surgery had been counselled about other non-operative therapeutic strategies, including, sildenafil (following its introduction in April 1998), intra-cavernosal injection therapy, intra-urethral therapy and vacuum constriction devices prior to making a decision regarding the surgery. Patients were counselled also about the risks and benefits of the surgery including implant infection, device malfunction, device migration, re-operation rates, as well as the ability for implant surgery to restore erectile rigidity and spontaneity.
All patients, both in-patient and ambulatory, had identical preoperative management. Specifically, patients were seen in the urology clinic one week before surgery, where they had a urinalysis performed. They were also given two prescriptions, one for ciprofloxacin (500 mg twice a day, Bayer Corp.) to be commenced 48 h prior to the operation as well as a prescription for 1% chlorhexidine soap for genital washing for the 7 days before the operation. Two hours before the operation, the patients had intravenous antibiotics administered (gentamicin 5 mg=kg i.v. ampicillin 1 g i.v.).
Patients underwent the implant surgery using either spinal or laryngeal mask general anesthesia. All procedures were performed through a transverse scrotal incision. The two-piece implant used was the Ambicor 1 device (AMS, Minneapolis, USA), while the three-piece implant used was the Alpha-1 1 device (Mentor Corp., Minneapolis, USA). The reservoir for the three-piece device was placed through the scrotal incision via the external inguinal ring into the space of Retzius. The indications for insertion of a two-piece rather than a three-piece device included a history of radical cystectomy, bilateral inguinal hernia surgery and patient choice. At the end of the case, the scrotal incision was infiltrated with 0.5% plain bupivicaine. Prior to leaving the operating room, the Foley catheter, which was placed intra-operatively was removed, a large scrotal compression dressing was placed (a scrotal support filled with fluffed gauze dressings).
The patients were discharged within 3 h of the operation, with prescriptions for ciprofloxacin (500 mg twice a day for 7 days), oral analgesics (hydrocodone 1 -2 pills every 4 -6 h). All patients were seen within 10 days of the operation and at 4 and 8 weeks post-operatively. At the 4-week postoperative visit, the patients were asked to account for any analgesic pills that had gone unused, as well as the date of their return to work. On this day, they were also counselled regarding the proper utilization of their penile implant. They were then instructed to inflate and deflate the device daily for the next month. Statistical analysis between the groups was conducted using a Student's t-test (Excel, Microsoft Corp., USA).
Results
From a demographic stand-point there was no difference in patient age, co-morbidity profile or post-operative follow-up between the two groups of patients ( Table 1 ). The distribution of two-piece and three-piece devices was also similar. There was a statistically significant greater number of secondary implant surgeries in the ambulatory group vs the inpatient group (43% vs 21%, P ¼ 0.03). There was no difference between the two groups in intra-operative parameters, such as, operating time or intra-operative estimated blood loss (Table 2 ). Time lost from work was similar in both groups approximating 7 days.
The mean number of analgesic pills ingested by the patients post-operatively was similar in both groups, averaging just under 30 pills per patient ( Table 2 ). There was no significant difference in post-operative complication rates between the two groups. In the ambulatory group, one patient was admitted from the recovery room because of urinary retention while another developed an implant infection at 2 weeks post-operatively that was dealt with by immediate explantation. In the in-patient group, one patient developed a massive scrotal hematoma, which, settled down with conservative management, while one patient developed an implant infection at 3 weeks post-operatively which was also dealt with by immediate explantion.
Discussion
Penile prosthetic surgery represents a well-recognized and highly effective form of management for the male with erectile dysfunction (ED). It represents, for most men and clinicians a thirdline therapy following oral agents, transurethral In-patient and out-patient prosthesis surgery JP Mulhall and K Bloom suppositories, vacuum devices and intra-cavernosal injection therapy. It assumes this position because of its level of invasiveness, its lack of reversibility and its cost. The concept of performing inflatable penile implant insertion on an out-patient basis is not novel in the medical literature. Garber cited a series of steps, which make ambulatory insertion feasible and safe. These include, a water-tight corporotomy closure, meticulous hemostasis, avoidance of surgical drain use, avoidance of post-operative catheters, the use of compression dressings, and the use of single dose vancomycin=gentamicin antibiotic prophylaxis, followed by a course of oral fluoroquinolone. 9 At our institution, these modifications have also been employed. In another series, 20 patients underwent out-patient placement of malleable and two-piece penile prosthesis utilizing regional (pudendal block) anesthesia. 11 Although this technique is a less appropriate form of anesthesia for placement of a three-piece device, the author does emphasize the ability to manage post-operative pain and bacterial prophylaxis of patients with oral pain medication and antibiotics prescribed prior to surgery.
In a similar study by Lubensky, 74 patients underwent three-piece inflatable penile prosthesis in the ambulatory setting. Only two patients (2.7%) encountered post-operative infection. No other complications were noted in this study. 10 Patients in this study were very satisfied with pain management post-operatively. Lubensky attributes success with analgesia to the use of anesthetic irrigating solution, post-operative ice packs, and adequate oral pain medication. In Garber's study of 95 patients who underwent penile prosthesis on an out-patient surgery basis, only one (1%) patient experienced post-operative infection and three patients encountered other complications, one with gross hematuria, while two experienced urinary retention requiring placement of a urethral catheter. The overall complication rate was 6.3%. 9 In the largest multi-center study of the Mentor Alpha-1 1 penile implant performed in an in-patient fashion, conducted by Goldstein et al, over a 2-y period, only 9.2% of 434 patients developed complications after placement of the device. Thirty patients (6.8%) required removal of the prosthesis and 2.8% experienced infection. 12 Our data are comparable to those found in the literature for both in-patient and ambulatory insertion of inflatable penile prostheses. Our overall complication rates of 6% in the in-patient group and 4% in the ambulatory group is similar to that cited in recent literature. Furthermore, post-operative infection rates were comparable between the in-patient group (3%) and the out-patient group (2%) supporting the fact that administration of prophylactic intravenous antibiotics combined with post-operative oral fluoroquinolones represents excellent infection prophylaxis.
Schwartz et al, in fact, have demonstrated that the use of parenteral antibiotics during insertion of inflatable prostheses may be replaced completely by the use of oral fluoroquinolones alone. 13 We utilize a single dose of ampicillin (1 g i.v.) combined with a single dose of aminoglycoside (gentamicin) at a dose of 5 mg=kg. This protocol has previously been shown to reduce aminoglycoside-induced nephrotoxicity and ototoxicity. 14 Other parameters evaluated in our study further support ambulatory performance of prosthetic implantation as safe and effective. Intra-operative blood loss and operative times were similar in both groups. Finally, time lost from work and narcotic use were similar in both groups. From a cost standpoint, at our institution, performance of penile implant surgery in an ambulatory setting reduced the cost of the procedure by a mean value of $2200 per patient. This confirms findings of other workers addressing the same issue. Buch and Taylor found that the elimination of in-patient penile implant surgery would decrease the expense of the procedure by approximately $2400. 15 
Conclusion
This is the first study in the literature, to the best of our knowledge, directly comparing in-patient and out-patient penile implant by a single surgeon. Our data confirm not only the feasibility, but, the safety and patient acceptance of performing inflatable penile prosthesis surgery in an ambulatory setting. Furthermore, no difference in intra-operative course, duration of time lost from work or the post-operative analgesic use between the two groups exists. At this point in time, at our institution, all primary implants and all secondary procedures for malfunctioning penile implants are performed in our ambulatory surgery center. In-patient prosthetic surgery is reserved for secondary procedures following prior implant infection or primary implants in men with significant co-morbidities that require post-operative monitoring. Ambulatory insertion of inflatable penile prostheses is a safe and costeffective approach to penile implant surgery.
